Doxycycline vs Pembrolizumab

## Doxycycline vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Doxycycline** and **Pembrolizumab**.

## Mechanism of Action

**Doxycycline**: Inhibits bacterial protein synthesis by binding 30S ribosomal subunit.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Doxycycline — 18-22 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Doxycycline — C22H24N2O8; Pembrolizumab — N/A.

**Molecular Weight**: Doxycycline — 444.4350 g/mol; Pembrolizumab — N/A.

**Type**: Doxycycline — Small molecule; Pembrolizumab — Antibody.